These effects align with traditional rodent models of psychosis-like deficits used for antipsychotic drug discovery, e.g. PPI deficits in rodents are reversed by drugs showing antipsychotic efficacy, and DRD2 is the classical antipsychotic drug target receptor. The gene discussed is DRD2; the disease is psychotic disorder.